Search by Drug Name or NDC
NDC 24571-0113-06 PRISMASOL 5.4; 2.44; 3.09; 6.46 g/L; g/L; g/L; g/L Details
PRISMASOL 5.4; 2.44; 3.09; 6.46 g/L; g/L; g/L; g/L
PRISMASOL is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE.
Product Information
NDC | 24571-0113 |
---|---|
Product ID | 24571-113_51955077-01ba-49f1-97b6-b2189b15e8aa |
Associated GPIs | 99720050002021 |
GCN Sequence Number | 066405 |
GCN Sequence Number Description | bicarb dial soln13-no Ca,K,dex SOLUTION 1.2 MEQ/L HEMODIALYS |
HIC3 | C1Y |
HIC3 Description | DIALYSIS SOLUTIONS |
GCN | 28666 |
HICL Sequence Number | 037016 |
HICL Sequence Number Description | BICARBONATE DIALYSIS SOLN NO.13 WITHOUT CALC,POTAS,DEXTROSE |
Brand/Generic | Brand |
Proprietary Name | PRISMASOL |
Proprietary Name Suffix | BK0/0/1.2 |
Non-Proprietary Name | magnesium chloride, lactic acid, sodium chloride and sodium bicarbonate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 5.4; 2.44; 3.09; 6.46 |
Active Ingredient Units | g/L; g/L; g/L; g/L |
Substance Name | LACTIC ACID, UNSPECIFIED FORM; MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
Labeler Name | Baxter Healthcare Corporation |
Pharmaceutical Class | Acidifying Activity [MoA], Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibit |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021703 |
Listing Certified Through | 2024-12-31 |
Package
NDC 24571-0113-06 (24571011306)
NDC Package Code | 24571-113-06 |
---|---|
Billing NDC | 24571011306 |
Package | 2 BAG in 1 CASE (24571-113-06) / 5 L in 1 BAG |
Marketing Start Date | 2008-10-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |